Compare CPRX & GRND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRX | GRND |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2006 | N/A |
| Metric | CPRX | GRND |
|---|---|---|
| Price | $24.32 | $13.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $32.60 | $22.40 |
| AVG Volume (30 Days) | 1.2M | ★ 1.6M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.94 | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $578,196,000.00 | $411,545,000.00 |
| Revenue This Year | $19.87 | $29.03 |
| Revenue Next Year | $7.21 | $21.87 |
| P/E Ratio | $13.83 | ★ N/A |
| Revenue Growth | 25.56 | ★ 28.97 |
| 52 Week Low | $19.05 | $11.73 |
| 52 Week High | $26.58 | $25.13 |
| Indicator | CPRX | GRND |
|---|---|---|
| Relative Strength Index (RSI) | 66.20 | 43.38 |
| Support Level | $22.67 | $13.24 |
| Resistance Level | $23.84 | $13.94 |
| Average True Range (ATR) | 0.68 | 0.42 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 70.80 | 49.87 |
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.